Rising prevalence of chronic diseases and increasing surgical procedures are some of the factors driving the Global Blood Transfusion Diagnostics Market says Fortune Business Insights in a report titled “Blood Transfusion Diagnostics Market Size, Share And Global Trend By Product Type (Instruments, Kits & Reagents), By Application (Blood Grouping, Disease Screening), By End-User (Hospitals Diagnostics Laboratories, Blood Banks, Plasma Fractionation Companies), And Geography Forecast Till 2026”.The cases of kidney diseases in patients are fostering the growth for the global blood transfusion market.
Browse Complete Report:
Major Key Players Mentioned:
- BAG Health Care GmbH
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd
- Immucor, Inc.
- DiaSorin S.p.A.
- Grifols, S.A. Ortho Clinical Diagnostics
- Quotient Limited.
FDA Approves ID CORE XT
Grifols, a global leader in plasma-derived medicines and diagnostic solutions, Launched ID CORE XT molecular diagnostic test for in-vitro diagnostic (IVD) after receiving approval from the Food and Drug Administration. The ID CORE XT will assist patients in ongoing transfusions, including cancer patients and individuals with hemoglobinopathies such as thalassemia and sickle-cell disease (SCD).
The launch of the new kit is predicted to fuel demand among patients, owing to the benefits of the test involving detailed information on relevant blood groups and types. In the past, several companies launched products for testing blood type which contributed positively to the market. For instance, Immucor Inc. announced a new molecular test for blood typing that provides comprehensive coverage of up to 11 HLA genes, unveiling the product MIA FOR A NGS FLEX HLA Typing Assay. The launch of innovative products by key companies for testing blood groups is a factor propelling the growth for the global blood transfusion market.
Increasing Surgical Procedures to Aid Market Growth
Blood transfusion is a medical procedure which involves injecting of donated blood into the patient’s body. This procedure is carried out for various reasons such as loss of blood during injury, surgery or in conditions such as kidney disease, cancer, leukemia and others.
Blood transfusions contain the transfusion of either one or multiple components of blood such as red blood cell (RBC), white blood cell (WBC), platelets and plasma or the whole blood with all its components. Blood transfusion diagnostics tests are carried out before the transfusion of blood or blood components from the donor to recipient. In 2018, The Leukemia & Lymphoma Society estimated 174,250 people in the U.S. diagnosed with leukemia, lymphoma or myeloma combined.
The American Kidney Fund estimated 10% of the population worldwide is affected by chronic kidney disease (CKD), and the prevalence of kidney disease is increasing in emerging nations countries such as India and China, due to the rising geriatric population. These factors are predicted to contribute significantly to the rapid growth of the global blood transfusion diagnostics market. In addition, the rising prevalence of infectious & chronic diseases along with increasing awareness regarding the safety of donated blood is fostering the growth for the blood transfusion diagnostic market. Nonetheless, the rising incidences of complications associated with the transfusion procedure are one of the factors hampering and restricting the growth of the global blood transfusion diagnostics market.
Get Sample PDF:
North America to Lead the Global Market
Geographically, the global blood transfusion diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are the two biggest markets for blood transfusion diagnostics at present and they are expected to dominate a large proportion of the global market in the forthcoming year. This is due to the increasing number of blood transfusions in the regions, stringent guidelines with respect to blood transfusions and the presence of a large number of voluntary donors. In Asia Pacific, countries such as Japan, China, and India accounted for the largest share of the global market in 2018. Asia Pacific is likely to grow on a considerable rate during the forecast period, due to rising demand for blood transfusion diagnostics and the developing healthcare infrastructure in the emerging markets of India and China.
Speak to Analyst:
View Related Reports: